Central CRF system perturbation in an Alzheimer's disease knockin mouse model.
Ontology highlight
ABSTRACT: Alzheimer's disease (AD) is often accompanied by changes in mood as well as increases in circulating cortisol levels, suggesting that regulation of the stress responsive hypothalamic-pituitary-adrenal (HPA) axis is disturbed. Here, we show that amyloid precursor protein (APP) is endogenously expressed in important limbic, hypothalamic, and midbrain nuclei that regulate hypothalamic-pituitary-adrenal axis activity. Furthermore, in a knockin mouse model of AD that expresses familial AD (FAD) mutations of both APP with humanized amyloid beta (hA?), and presenilin 1 (PS1), in their endogenous patterns (APP/hA?/PS1 animals), corticotropin releasing factor (CRF) levels are increased in key stress-related nuclei, resting corticosteroid levels are elevated, and animals display increased anxiety-related behavior. Endocrine and behavioral phenotypes can be normalized by loss of 1 copy of CRF receptor type-1 (Crfr1), consistent with a perturbation of central CRF signaling in APP/hA?/PS1 animals. However, reductions in anxiety and corticosteroid levels conferred by heterozygosity of CRF receptor type-1 do not improve a deficit in working memory observed in APP/hA?/PS1 mice, suggesting that perturbations of the CRF system are not the primary cause of decreased cognitive performance.
SUBMITTER: Guo Q
PROVIDER: S-EPMC3361634 | biostudies-literature | 2012 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA